title: [The prevention of pathospermia in patients with orchiepididymitis].
abstract: Spermatopathy persisting for a long time after therapy was detected in 48-60 per cent of the patients with gonorrheal orchiepididymitis. Intramuscular chymotrypsin, a proteolytic enzyme, in a dose of 2 mg twice daily (every 12 hrs) for 6-10 days, combined with an antibiotic, essentially (to 14.3-16.6 per cent) reduced the incidence rate of spermatogenesis disorders and alleviated the severity of these disorders vs. the patients treated with conventional therapy.
authors.forename: V N
authors.initials: VN
authors.lastname: Glozman
authors.forename: E S
authors.initials: ES
authors.lastname: Aganov
mesh_terms: D000328:Adult; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004823:Epididymitis / Q000150:complications* / Q000188:drug therapy; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D009920:Orchitis / Q000150:complications* / Q000188:drug therapy; D013094:Spermatozoa / Q000187:drug effects / Q000473:pathology*
vernacular_title: K voprosu o profilaktike patospermii u bol'nykh orkhoépididimitami.